
More than 2,000 lawsuits have been filed in the United States against the makers of Ozempic and Zepbound, with patients alleging life-threatening side effects linked to the popular weight-loss and diabetes drugs.
The consolidated litigation, centred in a Pennsylvania federal court, has moved into the discovery stage as regulators update product labels and drugmakers face mounting legal and public scrutiny.